A clinical guide by the European Menopause and Andropause Society (EMAS) on lichen sclerosus with summary recommendations has been published in Maturitas. This announcement was made by Elsevier, a world-leading provider of scientific, technical and medical information products and services.
Vulvar lichen sclerosus (LS) is a chronic inflammatory disease which affects genital labial, perineal and perianal areas, producing significant discomfort and psychological distress. The purpose of this clinical guide is to provide advice on early recognition and treatment to prevent delay in management. Women presenting with vulvar pruritus and pain should be examined by a health professional with expertise in vulvar skin disorders. First line treatment is a topical corticosteroid cream and calcineurin inhibitors are second line. Surgical management such as vulvectomy or cryosurgery is reserved for women with malignancy or post-inflammatory sequelae.
These and other recommendations presented in the EMAS clinical guide are published in the article: 'EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women by Faustino R. Pérez-López, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Margaret Rees, Karin Schenck-Gustafsson, Florence Tremollieres, Yvonne T. van der Schouw and Tommaso Simoncini.' (doi:10.1016/j.maturitas.2012.12.006). The article appears in Maturitas
Volume 74, Issue 3 (March 2013) published by Elsevier.